Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

217.99 -16.65 (-7.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
25 26 Next >
News headline image
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 ↗
These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector. 
Via InvestorPlace
News headline image
Expert Ratings for Axsome Therapeutics ↗
 
Via Benzinga
News headline image
Baidu To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Monday ↗
Keybanc boosted the price target for Camping World Holdings, Inc. (NYSE: CWH) from $28 to $36. Keybanc analyst Noah Zatzkin maintained an Overweight rating. Camping World shares rose 1.4% to $32.04 in... 
Via Benzinga
News headline image
Got $500? 3 Growth Stocks to Buy That Could Double Your Money ↗
There's no guarantee these stocks will deliver 2x returns over the next few years, but their prospects look good. 
Via The Motley Fool
News headline image
Axsome Therapeutics to Report Second Quarter 2023 Financial Results on August 7
Axsome to host conference call and webcast on Monday, Aug. 7, 2023, at 8:00 a.m. Eastern Time 
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Shares of Axsome Therapeutics Fell Wednesday ↗
The biopharmaceutical company announced a $225 million stock sale. 
Via The Motley Fool
News headline image
2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗
These companies are coming into their own. 
Via The Motley Fool
News headline image
Axsome Therapeutics Initiates FOCUS Phase 3 Trial of Solriamfetol for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
5 Top Stocks for July ↗
This basket of stocks has it all, including growth, dividend income, and value. 
Via The Motley Fool
News headline image
Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
News headline image
Why Is Xponential Fitness (XPOF) Stock Up 19% Today? ↗
Xponential Fitness (XPOF) stock is climbing higher on Wednesday as the company strikes back against a short report from Fuzzy Panda Research. 
Via InvestorPlace
News headline image
Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today? ↗
Axsome Therapeutics (AXSM) stock is heading lower on Wednesday as investors react to the company pricing a public share offering. 
Via InvestorPlace
News headline image
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock ↗
Markets could have a tough time building on gains from Tuesday. 
Via The Motley Fool
News headline image
Where Will Axsome Therapeutics Be in 3 Years? ↗
The stock soared more than 100% last year. 
Via The Motley Fool
News headline image
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again. ↗
This small biotech could become much bigger in just a few years. 
Via The Motley Fool
News headline image
Is Axsome Therapeutics Stock a Screaming Buy? ↗
The biotech could be staring down an enormous commercial opportunity. 
Via The Motley Fool
News headline image
Axsome Therapeutics Stock Is Moving Lower: What's Going On? ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock. 
Via Benzinga
News headline image
The Best Stocks to Invest $20,000 in Right Now ↗
You can invest in these companies with $20,000 -- or even a lot less. 
Via The Motley Fool
News headline image
Axsome Therapeutics Announces Proposed Public Offering of Common Stock
From Axsome Therapeutics, Inc.
Via GlobeNewswire
News headline image
2 Low-Priced Stocks That Could Make You Richer ↗
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
News headline image
3 Monster Stocks in the Making to Buy Right Now ↗
They're not monsters now -- but just give them some time. 
Via The Motley Fool
News headline image
Why Axsome Therapeutics Stock Is Rising Today ↗
Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares are trading higher Wednesday following a recent corporate presentation. 
Via Benzinga
News headline image
Analyst Expectations for Axsome Therapeutics's Future ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Buy as Companies Ink Major Deals ↗
Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. 
Via InvestorPlace
News headline image
Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now? ↗
Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics. 
Via The Motley Fool
News headline image
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review ↗
Stocks kept powering higher despite, but the Nasdaq is looking extended. 
Via Investor's Business Daily
News headline image
Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts ↗
The company's biggest products treats depression and could be used in other conditions. 
Via Investor's Business Daily
News headline image
3 No-Brainer Stocks to Buy in June ↗
These biopharma stocks could be big winners. 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.